With federal COVID-19 funds dwindling, Pfizer’s vaccine may cost between $110 and $130 per dose once it is sold commercially, a company spokesperson told The Wall Street Journal in an Oct. 20 report.
Read the full post on Becker's Hospital Review - Healthcare News
